Cambridge Investment Research Advisors, Inc. Baxter International Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 50,558 shares of BAX stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,558
Previous 29,651 70.51%
Holding current value
$1.64 Million
Previous $992,000 93.55%
% of portfolio
0.01%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
BUY
$32.85 - $40.26 $686,794 - $841,715
20,907 Added 70.51%
50,558 $1.92 Million
Q2 2024

Jul 26, 2024
SELL
$32.87 - $43.55 $100,680 - $133,393
-3,063 Reduced 9.36%
29,651 $992,000
Q1 2024

Apr 24, 2024
SELL
$37.88 - $43.77 $126,594 - $146,279
-3,342 Reduced 9.27%
32,714 $1.4 Million
Q4 2023

Feb 09, 2024
SELL
$31.71 - $38.95 $126,903 - $155,877
-4,002 Reduced 9.99%
36,056 $1.39 Million
Q3 2023

Oct 24, 2023
BUY
$37.32 - $49.29 $190,145 - $251,132
5,095 Added 14.57%
40,058 $1.51 Million
Q2 2023

Jul 13, 2023
BUY
$39.98 - $47.68 $60,449 - $72,092
1,512 Added 4.52%
34,963 $1.59 Million
Q1 2023

May 11, 2023
BUY
$37.58 - $52.57 $85,231 - $119,228
2,268 Added 7.27%
33,451 $1.36 Million
Q4 2022

Feb 08, 2023
SELL
$49.7 - $57.71 $8,598 - $9,983
-173 Reduced 0.55%
31,183 $1.59 Million
Q3 2022

Oct 17, 2022
BUY
$53.86 - $66.8 $3,016 - $3,740
56 Added 0.18%
31,356 $1.69 Million
Q2 2022

Jul 13, 2022
BUY
$63.83 - $80.0 $110,425 - $138,400
1,730 Added 5.85%
31,300 $2.01 Million
Q1 2022

May 12, 2022
SELL
$76.85 - $89.45 $384,634 - $447,697
-5,005 Reduced 14.48%
29,570 $2.29 Million
Q4 2021

Feb 03, 2022
BUY
$74.57 - $87.19 $454,056 - $530,899
6,089 Added 21.38%
34,575 $2.97 Million
Q3 2021

Nov 02, 2021
SELL
$73.77 - $83.61 $124,449 - $141,050
-1,687 Reduced 5.59%
28,486 $2.29 Million
Q2 2021

Aug 10, 2021
SELL
$80.5 - $88.01 $45,160 - $49,373
-561 Reduced 1.83%
30,173 $2.43 Million
Q1 2021

May 07, 2021
BUY
$76.38 - $86.03 $546,269 - $615,286
7,152 Added 30.33%
30,734 $2.59 Million
Q4 2020

Feb 04, 2021
BUY
$75.39 - $82.36 $3,467 - $3,788
46 Added 0.2%
23,582 $1.89 Million
Q3 2020

Oct 29, 2020
SELL
$78.33 - $90.73 $12,376 - $14,335
-158 Reduced 0.67%
23,536 $1.89 Million
Q2 2020

Jul 27, 2020
BUY
$78.66 - $94.14 $73,075 - $87,456
929 Added 4.08%
23,694 $2.04 Million
Q1 2020

May 08, 2020
SELL
$71.57 - $93.3 $104,062 - $135,658
-1,454 Reduced 6.0%
22,765 $1.85 Million
Q4 2019

Feb 04, 2020
SELL
$76.7 - $88.45 $20,785 - $23,969
-271 Reduced 1.11%
24,219 $2.03 Million
Q3 2019

Nov 06, 2019
BUY
$81.4 - $89.78 $30,687 - $33,847
377 Added 1.56%
24,490 $2.14 Million
Q3 2019

Oct 28, 2019
SELL
$81.4 - $89.78 $79,365 - $87,535
-975 Reduced 3.89%
24,113 $2.11 Million
Q2 2019

Aug 15, 2019
SELL
$73.44 - $82.41 $18,066 - $20,272
-246 Reduced 0.97%
25,088 $0
Q1 2019

May 08, 2019
BUY
$64.48 - $81.31 $130,572 - $164,652
2,025 Added 8.69%
25,334 $0
Q4 2018

Feb 05, 2019
SELL
$61.45 - $77.8 $80,069 - $101,373
-1,303 Reduced 5.29%
23,309 $1.53 Million
Q3 2018

Nov 02, 2018
BUY
$70.71 - $77.75 $78,205 - $85,991
1,106 Added 4.71%
24,612 $0
Q2 2018

Aug 10, 2018
BUY
$63.43 - $75.41 $35,457 - $42,154
559 Added 2.44%
23,506 $0
Q1 2018

May 09, 2018
SELL
$62.56 - $72.26 $13,387 - $15,463
-214 Reduced 0.92%
22,947 $0
Q4 2017

Feb 22, 2018
SELL
$61.45 - $66.05 $557,412 - $599,139
-9,071 Reduced 28.14%
23,161 $0
Q3 2017

Nov 07, 2017
SELL
$59.5 - $64.61 $63,189 - $68,615
-1,062 Reduced 3.19%
32,232 $2.02 Million
Q2 2017

Aug 08, 2017
BUY
N/A
33,294
33,294 $2.02 Million

Others Institutions Holding BAX

# of Institutions
970
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email